|
|
||||||||
1From the Institute of Ophthalmology, University College London, London, United Kingdom; and the 2Department of Ophthalmology, Addenbrookes Hospital, Cambridge, United Kingdom.
| Abstract |
|---|
|
|
|---|
METHODS. Eleven members of a five-generation, nonconsanguineous British family were examined clinically and also underwent automated perimetry, electrodiagnostic testing, fundus fluorescein angiography, and fundus autofluorescence imaging. Blood samples were taken for DNA extraction and linkage analysis was performed.
RESULTS. The phenotype is characterized by bulls-eye macular dystrophy first evident in the first or second decade of life. There is mild visual impairment, central scotomata, and electrophysiological testing indicates that most affected individuals have disease confined to the central retina but older subjects have more widespread rod and cone abnormalities, demonstrated by flash ERG. Genetic linkage analysis established linkage to chromosome 4 at p15.2-16.3 with a maximum lod score of 3.03 at a recombination fraction of 0.00 for marker D4S391. The locus for this autosomal dominant macular dystrophy lies between flanking markers D4S3023 and D4S3022, and overlaps the Stargardt 4 locus.
CONCLUSIONS. A new locus was identified for a bulls-eye macular dystrophy on the short arm of chromosome 4.
|
In the present study we identified a locus on the short arm of chromosome 4 (4p) in a family with a dominantly inherited macular dystrophy in which there is a relatively mild phenotype.
| Patients and Methods |
|---|
|
|
|---|
Clinical Assessment
Eleven members of a five-generation, nonconsanguineous British family were examined (Fig. 1) . Although there was no male-to-male transmission, males and females were equally affected, and autosomal dominant inheritance is thought to be most likely. A full medical and ophthalmic history was obtained and an ophthalmic examination performed. Color vision testing was performed with Hardy, Rand, Rittler (HRR) plates (American Optical Company, New York, NY). Affected subjects also underwent automated visual field perimetry (Humphrey Perimeter; Humphrey Systems, Dublin, CA), color fundus photography, and fundus autofluorescence imaging with a confocal scanning laser ophthalmoscope (cSLO) (Zeiss prototype; Carl Zeiss Inc., Oberkochen, Germany). Electrodiagnostic assessment included an electro-oculogram (EOG), a flash electroretinogram (ERG), and pattern ERG (PERG), according to the protocols recommended by the International Society for Clinical Electrophysiology of Vision.22 23 24 Patients IV:2 and V:1 underwent fundus fluorescein angiography (FFA).
|
Linkage Analysis Method
Genotyping.
Genotyping was performed using markers from commercial linkage mapping sets (ABI MD-10 and HD-5, ver. 2.0; Linkage Mapping Sets; Applied Biosystems, Foster City, CA). These sets allow approximately 10- and 5-cM resolution of the human genome, respectively, and consist of fluorescence-labeled PCR primer pairs for 800 highly polymorphic dinucleotide repeat microsatellite markers chosen from a human linkage map provided by Gènèthon (www.genethon.fr; provided in the public domain by the French Association against Myopathies, Evry, France).25 26 27
PCR reactions were performed for each marker individually in a 5-µL reaction volume, containing 25 ng DNA, 15 mM Tris-HCl (pH 8.0), 50 mM KCl, 2.5 mM MgCl2, 250 µM each dNTP, 1.25 pmol each primer and 0.25 U Taq polymerase (AmpliTaq Gold; Applied Biosystems). Reactions were performed on a thermocycler (model 9600; Perkin Elmer, Wellesley, MA) with a standard thermocycling profile for all markers. This consisted of an initial denaturation of 12 minutes immediately followed by 10 cycles of 95°C for 15 seconds, 55°C for 15 seconds, and 72°C for 30 seconds and then by 20 cycles of 89°C for 15 seconds, 55°C for 15 seconds, and 72°C for 30 seconds, with a single final extension step of 72°C for 10 minutes.
PCR products for selected sets of markers were pooled, diluted, and denatured in formamide and size fractionated using a gene analyzer (ABI 3100; Applied Biosystems). PCR products were automatically sized by the accompanying software (3100 Data Collection Software, ver. 1.0.1; Applied Biosystems), with ROX used as the size standard, and scored by using GeneMapper (version 2.0; Applied Biosystems). Data were checked for genotyping errors using PedCheck (developed by Jeff OConnell, University of Pittsburgh, Pittsburgh, PA).28
Linkage Analysis.
Subjects were classified as affected, unaffected, or status unknown according to their clinical status. Linkage analysis was performed by using standard lod score methods. Two point lod scores were calculated using the MLINK program of the LINKAGE (ver. 5.1) package (http:www.hgmp.mrc.ac.uk/; provided in the public domain by the Human Genome Mapping Project Resources Center, Cambridge, UK).29 A fully penetrant dominant model with a disease allele frequency of 0.0001 was assumed. Marker allele frequencies were assumed to occur at equal frequencies, because population allele frequencies were not available.
| Results |
|---|
|
|
|---|
Patient V:1
A 17-year-old woman (the proband) was first examined at age 13 having noticed blurred vision when reading and metamorphopsia. This difficulty with reading had gradually worsened. There were no reported problems with night vision. Visual acuity was 6/9 bilaterally. HRR testing revealed a mild red-green defect and medium tritan defect bilaterally. Dilated fundoscopy revealed bilateral macular retinal pigment epithelium (RPE) mottling and atrophy with fine perifoveal red granular patches. Visual fields demonstrated mildly reduced central sensitivity. Fundus autofluorescence revealed a ring of moderately increased perifoveal autofluorescence bilaterally. Fluorescein angiography showed localized masking of the choroidal fluorescence in the perifoveal area. The PERG P50 component was mildly subnormal. EOG and flash ERG were normal.
Patient V:3
This 9-year-old boy had occasional difficulty with reading small print. Visual acuity was 6/6 bilaterally. HRR revealed mild red-green defect bilaterally. Fundoscopy revealed a bilateral prominent foveal reflex and a red-speckled appearance at the level of the RPE. Fundus autofluorescence revealed a mild perifoveal ring of increased autofluorescence. The ERG was normal. PERG and EOG were not performed because of poor cooperation.
Patient V:4
This 14-year-old girl was asymptomatic, except for noticing some difficulty with color vision, especially the color blue. Visual acuity was found to be 6/5 bilaterally. Color testing with HRR plates revealed a mild tritan and red-green defect in the left eye and normal color vision on the right. Fundus examination revealed a mild abnormality of the macula with bilateral red-speckled appearance at the level of the RPE, more prominent in the left than the right eye. There was once again a prominent foveal reflex bilaterally. Fundus autofluorescence was unremarkable. PERG, ERG, and EOG were normal.
Patient IV:2
This 41-year-old woman reported glare at night but was otherwise asymptomatic. Visual acuity was 6/5 bilaterally. Color vision assessment with the HRR plates revealed generalized dyschromatopsia affecting protan, deutan, and tritan axes. Fundoscopy revealed bilateral macular RPE mottling with a dark red perifoveal region (Fig. 2A) . Visual field testing revealed bilateral central scotomata. Fundus autofluorescence imaging revealed bilateral bulls-eye lesions, comprising a ring of decreased perifoveal autofluorescence bordered peripherally and centrally (to a lesser extent) by increased autofluorescence (Fig. 2B) . Fluorescein angiography revealed masking of the choroidal fluorescence in the perifoveal area (Fig. 2C) . There was no recordable PERG, but EOG and ERG were normal.
|
Patient III:2
This 63-year-old woman was first seen at age 24, reporting difficulty with reading and bilateral central visual field defects. Visual field testing at first presentation with Bjerrums tangent screen revealed bilateral central scotomata. Visual acuity at that time was 6/4 bilaterally. Granular pigmentation was noted at both maculae. Over a period of 35 years, visual acuity had gradually deteriorated to 6/24 in the right eye and 6/36 in the left. Fundoscopy revealed a bulls-eye maculopathy. The PERG was unrecordable from either eye. Rod and cone flash ERG responses were subnormal, suggesting a more widespread retinal dysfunction with disease progression (Fig. 3) . EOG was not possible because of lack of cooperation.
|
Patients V:2, V:5, V:6, IV:3, and III:8
These patients were also assessed and were found to be asymptomatic, with clinical examination producing entirely normal findings.
Linkage Studies
Markers previously known to be linked to Stargardt disease (STGD) and cone-rod dystrophy (CORD) were examined in the first instance. No significant linkage was found in the following chromosome regions: CORD6 on 17p,30 CORD7 on 6q,31 CORD8 on 1q,32 GCAP on 6p,33 STGD1 on 1p,3 and STGD3 on 6q.4 In total approximately 50% of the genome was screened involving genotyping of 195 markers before significant linkage was established to 4p15.2-16.3 with a maximum lod score of 3.03 at a recombination fraction of 0.00 for marker D4S391 (Table 2) .
|
| Discussion |
|---|
|
|
|---|
The term bulls-eye maculopathy (BEM) was first introduced to describe the characteristic appearance of chloroquine retinopathy.34 Bulls-eye lesions have since been reported in cone dystrophy and CORD,35 rod-cone dystrophy,36 and in some forms of macular dystrophy.37 38 39 The pathogenesis of BEM is poorly understood. The characteristic appearance in which there is annular RPE atrophy, and central sparing may correspond to the pattern of lipofuscin accumulation in the RPE, which in healthy individuals is highest at the posterior pole and shows a depression at the fovea.40 41 The initially spared center usually becomes involved as the disease progresses.
Advances in ocular imaging have resulted in a new technique to visualize the RPE, taking advantage of its intrinsic fluorescence derived from lipofuscin.42 43 44 Autofluorescence imaging with a cSLO can provide useful information about the distribution of lipofuscin in the RPE and give indirect information on the level of metabolic activity of the RPE which is largely determined by the rate of turnover of photoreceptor outer segments.44 There is evidence of continuous degradation of autofluorescent material in the RPE.44 Progressive loss of lipofuscin occurs when there is reduced metabolic demand because of photoreceptor cell loss, and this may explain the decreased autofluorescence (AF) seen in areas of photoreceptor cell loss in eyes with retinitis pigmentosa and rod-cone dystrophies.44 Areas of increased AF correspond to a group of RPE cells containing higher quantities of lipofuscin than their neighbors and may represent areas at high risk for photoreceptor cell loss.40 It has been demonstrated histologically that the number of photoreceptor cells is reduced in the presence of increased quantities of lipofuscin in the RPE, leading to the proposal that autofluorescent material may accumulate before cell death.45 Increased lipofuscin may reflect either increased outer segment turnover or the inability of the RPE to process outer segment debris. In our family concentric areas of increased AF at the macula were evident in some individuals before there was ophthalmoscopic evidence of retinal atrophy. This may suggest that the primary site of dysfunction is in the RPE, but the findings of a normal EOG indicate that there is no widespread RPE abnormality. Alternatively, the increased AF could occur as a result of primary disease of the photoreceptors, which in the early stages of the disease is confined to the macular region but becomes more widespread in the late stages.
In our family we established linkage to 4p15.2-16.3. This region contains the candidate gene PROML1, encoding human prominin (mouse)-like-1 which belongs to the prominin family of 5-transmembrane domain proteins. PROML1 is expressed in retinoblastoma cell lines and adult retina, and the product of the mouse orthologue (prom) is concentrated in membrane evaginations at the base of the outer segments of rod photoreceptors. A homozygous mutation in PROML1 has been identified in an Indian pedigree with autosomal recessive retinal dystrophy. The mutation results in the production of a truncated protein, and functional studies in transfected CHO cells have demonstrated that the truncated prominin protein fails to reach the cell surface, indicating that the loss of prominin may lead to retinal degeneration through impaired generation of evaginations or conversion to outer segment disks.46
A locus for an autosomal dominant Stargardt-like disease has also been mapped to the short arm of chromosome 4 (STGD4) in a Caribbean family.5 Analysis of extended haplotypes localized the disease gene to a 12-cM interval between loci D4S1582 and D4S2397. This interval overlaps with our defined MCDR2 region. However our pedigree differs considerably from that of the Caribbean family, in that neither of our patients who underwent FFA demonstrated the characteristic dark choroid pattern that was seen in the Caribbean patients and our patients did not have the retinal flecks that were prominent in the Stargardt-like pedigree. The macular dystrophy we report appears to be clinically distinct from the STGD4 disorder. Therefore, even if both disorders are allelic, it is likely that different mutations are involved in their etiology. An alternative explanation is that the two disorders are caused by mutations in two different adjacent genes on 4p. The true situation will be resolved only by the identification of the underlying genetic mutations.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication July 16, 2002; revised October 8, 2002; accepted November 7, 2002.
Disclosure: M. Michaelides, None; S. Johnson, None; A. Poulson, None; K. Bradshaw, None; C. Bellmann, None; D.M. Hunt, None; A.T. Moore, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Anthony T. Moore, Institute of Ophthalmology, University College London, 11-43 Bath Street, London, EC1V 9EL, UK; tony.moore{at}ucl.ac.uk.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M Michaelides, L L Chen, M A Brantley Jr, J L Andorf, E M Isaak, S A Jenkins, G E Holder, A C Bird, E M Stone, and A R Webster ABCA4 mutations and discordant ABCA4 alleles in patients and siblings with bull's-eye maculopathy Br. J. Ophthalmol., December 1, 2007; 91(12): 1650 - 1655. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z Yang, G Kitsos, Z Tong, M Payne, S Gorezis, K Psilas, M Grigoriadou, Y Zhao, S Kamaya, G Aperis, et al. A novel locus on 19q13 associated with autosomal-dominant macular dystrophy in a large Greek family J. Med. Genet., December 1, 2006; 43(12): e57 - e57. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bowes Rickman, J. N. Ebright, Z. J. Zavodni, L. Yu, T. Wang, S. P. Daiger, G. Wistow, K. Boon, and M. A. Hauser Defining the Human Macula Transcriptome and Candidate Retinal Disease Genes Using EyeSAGE Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2305 - 2316. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ayyagari, M. N. A. Mandal, A. J. Karoukis, L. Chen, N. C. McLaren, M. Lichter, D. T. Wong, P. F. Hitchcock, R. C. Caruso, S. E. Moroi, et al. Late-Onset Macular Degeneration and Long Anterior Lens Zonules Result from a CTRP5 Gene Mutation Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3363 - 3371. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Michaelides, D M Hunt, and A T Moore The genetics of inherited macular dystrophies J. Med. Genet., September 1, 2003; 40(9): 641 - 650. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |